Method of reducing toxicity of anticancer agents
AssigneeHealth Research, Inc.
InventorsYoucef M. Rustum, Shousong Cao, Farukh Durrani
Life of this patent
Estimating the term…
Abstract
The present invention discloses a method for enhancing the efficacy of anti-cancer agents. The method comprises administering to an individual, in need of such a treatment, an anti-cancer agent and a selenium compound. The selenium compounds may be administered before, during or after administration of the anti-cancer agent.
Claims18
A method for reducing the in vivo toxicity of anticancer agents comprising the steps of administering to an individual in need of treatment a therapeutically effective dose of the anticancer agent and a selenium compound wherein the toxicity induced by the anticancer agent is less than the toxicity induced in the absence of administered selenium compound.
A method for using an anticancer agent at a higher than therapeutic dose comprising the steps of administering to an individual in need of treatment a higher than therapeutic dose of the anticancer agent and a selenium compound, wherein the toxicity of the anticancer agent is reduced with the administration of the selenium compound.
Dependencies are inferred from the claim text.